UB Paderborn / Katalog / Suche / in CDI

1 – 13 von 13

Sortiert nach

Decrease of the atrial fibrillatory rate, increased organization of the atrial rhythm and termination of atrial fibrillation by AZD7009

Journal of electrocardiology, 2013, Vol.46 (1), p.29-35

2013

Volltextzugriff (PDF)

Cardiac arrest in COVID-19: characteristics and outcomes of in- and out-of-hospital cardiac arrest. A report from the Swedish Registry for Cardiopulmonary Resuscitation

European heart journal, 2021, Vol.42 (11), p.1094-1106

2021

Volltextzugriff (PDF)

Inverse Correlation between the Atrial Fibrillatory Rate and the Ventricular Repolarization Time: Observations at Baseline and after an Intravenous Infusion of a Combined Potassium and Sodium Current Blocker

Annals of noninvasive electrocardiology, 2016-05, Vol.21 (3), p.236-245

2016

Volltextzugriff (PDF)

T wave inversions following ablation of 125 posteroseptal accessory pathways

International journal of cardiology, 2006-01, Vol.106 (1), p.75-81

2006

Volltextzugriff (PDF)

In Silico Predictions and In Vivo Results of Drug-Drug Interactions by Ketoconazole and Verapamil on AZD1305, a Combined Ion Channel Blocker and a Sensitive CYP3A4 Substrate

Clinical pharmacology in drug development, 2016-09, Vol.5 (5), p.364-373

2016

Volltextzugriff (PDF)

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy

Thrombosis research, 2011-02, Vol.127 (2), p.91-99

2011

Volltextzugriff (PDF)

Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation

Journal of electrocardiology, 2014-05, Vol.47 (3), p.316-323

2014

Volltextzugriff (PDF)

Abstract 5621: A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy

Circulation (New York, N.Y.), 2009-11, Vol.120 (suppl_18)

2009

Volltextzugriff (PDF)

QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2011-06, Vol.11 (3), p.199

2011

Volltextzugriff (PDF)

Prediction of drug-related morphological changes of the T wave

Scandinavian cardiovascular journal : SCJ, 2010-08, Vol.44 (4), p.215-222

2010

Volltextzugriff (PDF)

QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation: A Double-Blind, Randomized, Placebo-Controlled Trial

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2011-01, Vol.11 (3), p.199-208

2011

Volltextzugriff (PDF)

Rapid Conversion of Persistent Atrial Fibrillation to Sinus Rhythm by Intravenous AZD7009

Journal of clinical pharmacology, 2009-03, Vol.49 (3), p.312-322

2009

Volltextzugriff (PDF)

A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy

82nd Scientific Session of the American-Heart-Association,Orlando, FL, United States,2009-11-14 - 2009-11-18, 2009, Vol.120 (18), p.1129

2009

Volltextzugriff (PDF)

1 – 13 von 13

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(12)
Tagungsberichte
(1)

Sprache

Englisch
(13)

Erscheinungsjahr

n.n

Thema

Humans
(10)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Male
(9)
Middle Aged
(9)
Aged
(8)
Cardiac And Cardiovascular Systems
(8)
Cardiovascular System & Cardiology
(8)
Female
(8)
Kardiologi
(8)
Medicin Och Hälsovetenskap
(8)
Atrial Fibrillation
(7)
Atrial Fibrillation - Drug Therapy
(7)
Cardiac & Cardiovascular Systems
(7)
Medical And Health Sciences
(7)
Aged, 80 And Over
(6)
Atrial Fibrillation - Physiopathology
(6)
Adult
(5)
Clinical Medicine
(5)
Double-Blind Method
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Decrease of the atrial fibrillatory rate, increased organization of the atrial rhythm and termination of atrial fibrillation by AZD7009

Cardiac arrest in COVID-19: characteristics and outcomes of in- and out-of-hospital cardiac arrest. A report from the Swedish Registry for Cardiopulmonary Resuscitation

Inverse Correlation between the Atrial Fibrillatory Rate and the Ventricular Repolarization Time: Observations at Baseline and after an Intravenous Infusion of a Combined Potassium and Sodium Current Blocker

T wave inversions following ablation of 125 posteroseptal accessory pathways

In Silico Predictions and In Vivo Results of Drug-Drug Interactions by Ketoconazole and Verapamil on AZD1305, a Combined Ion Channel Blocker and a Sensitive CYP3A4 Substrate

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy

Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation

Abstract 5621: A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy

QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation

Prediction of drug-related morphological changes of the T wave

QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation: A Double-Blind, Randomized, Placebo-Controlled Trial

Rapid Conversion of Persistent Atrial Fibrillation to Sinus Rhythm by Intravenous AZD7009

A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy

Suchergebnisse filtern